Prices are updated after-hours

Manufacturing 2022 - 06 - 09

Bionik Laboratories Corp

BNKL | $0.1 -39.39% 1.8K

|

(0.0% 1d) (0.0% 1m) (-79.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-87.07% volume)
Earnings Calendar:
Market Cap: $ 1,248,043

Sec Filling | Patents | 19 employees

bionik laboratories (otcqx: bnkl) is a pioneering medical device and robotics company developing transformational robotic rehabilitation technologies for individuals with neurological disorders. the company is dedicated to provide individuals with restricted mobility an improvement in overall health, comfort, accessibility, and quality of life through the commercialization of its proprietary products. the company’s lead program, arke™ is the most comprehensive lower-body exoskeleton that allows paraplegics and as well as other wheelchair users the ability to rehabilitate through walking and other motion. currently in clinical development, arke will initially be used in a rehabilitation environment, with the goal of being made available for home use.

add to watch list Paper trade email alert is off

Vicinity Motor Corp

VEV | $0.656 -4.44% -4.65% 34K

|

(0.0% 1d) (-11.4% 1m) (-11.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (34.66% volume)
Earnings Calendar: 2023-11-15
Market Cap: $ 29,958,015
http://grandewest.com/
Sec Filling | Patents | 2021 employees

(CA) Vicinity Motor Corp. is a leading supplier of electric, CNG and clean-diesel vehicles for both public and commercial enterprise use in the U.S and Canada. The Company's flagship line of Vicinity™ buses, which maintains a market segment leadership position in Canada, is produced by the Company's world-class manufacturing partners and will be produced at the soon to be completed Buy America Act compliant assembly facility in the State of Washington. Vicinity's innovative Vicinity Lightning™ EV bus, enabled through a strategic supply agreement with BMW for batteries and components, seeks to lead the global transition to more sustainable transit vehicles in the private and public markets.

batteries eletrical vehicles

add to watch list Paper trade email alert is off

SavMobi Technology Inc.

SVMB | $3.58 -85.43% 220

|

(0.0% 1d) (-4.5% 1m) (143.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1592.31% volume)
Earnings Calendar:
Market Cap: $ 19,029,175

Sec Filling | Patents | 2 employees

add to watch list Paper trade email alert is off

MusclePharm Corp

MSLP | $0.0002

|

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (406.28% volume)
Earnings Calendar:
Market Cap: $ 6,677

Sec Filling | Patents | 27 employees

add to watch list Paper trade email alert is off

ON TRACK INNOVATIONS LTD

OTIVF | $0.059

|

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (39.5% 3d) (0.0% 7d) (62.09% volume)
Earnings Calendar:
Market Cap:
https://www.otiglobal.com
Sec Filling | Patents | 121 employees

(IL)

add to watch list Paper trade email alert is off

Velo3D Inc - New

VLD 4 | $0.25 -5.23% 2.8% 5.8M

|

(0.0% 1d) (-41.9% 1m) (-87.4% 1y) (0.0% 2d) (0.0% 3d) (-8.8% 7d) (13.0% volume)
Earnings Calendar: 2024-03-26
Market Cap: $ 65,426,147
https://www.velo3d.com
Sec Filling | Patents | 2 employees

Velo3D is a metal 3D printing technology company. 3D printing—also known as additive manufacturing (AM)—has a unique ability to improve the way high-value metal parts are built. However, legacy metal AM has been greatly limited in its capabilities since its invention almost 30 years ago. This has prevented the technology from being used to create the most valuable and impactful parts, restricting its use to specific niches where the limitations were acceptable. Velo3D has overcome these limitations so engineers can design and print the parts they want. The company’s solution unlocks a wide breadth of design freedom and enables customers in space exploration, aviation, power generation, energy and semiconductor to innovate the future in their respective industries. Using Velo3D, these customers can now build mission-critical metal parts that were previously impossible to manufacture. The end-to-end solution includes the Flow™ print preparation software, the Sapphire® family of printers, and the Assure™ quality control system—all of which are powered by Velo3D’s Intelligent Fusion™ manufacturing process. The company delivered its first Sapphire® system in 2018 and has been a strategic partner to innovators such as SpaceX, Honeywell, Honda, Chromalloy, and Lam Research. Velo3D has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021.

energy semiconductor

add to watch list Paper trade email alert is off

Centessa Pharmaceuticals plc - ADR

CNTA | $10.555 0.24% 0.24% 150K

|

(0.0% 1d) (-6.8% 1m) (122.4% 1y) (0.0% 2d) (0.0% 3d) (2.3% 7d) (171.77% volume)
Earnings Calendar:
Market Cap: $ 1,058,728,247
https://www.centessa.com
Sec Filling | Patents | 2021 employees

Centessa Pharmaceuticals plc aims to bring impactful new medicines to patients by combining the strengths of an asset-centric model with the benefits of scale and diversification typical of larger R&D organizations. The asset-centric model refers to a highly specialized, singular-focused company that is led by a team of well-recognized subject matter experts. Centessa wholly owns ten of these asset-centric companies. The companies’ programs range from discovery-stage to late-stage development and include diverse therapeutic areas such as oncology, hematology, immunology/inflammation, neuroscience, hepatology, pulmonology and nephrology. Centessa’s asset-centric companies are overseen by the Centessa management team, which sets overall strategy and direction, provides leadership and expertise, and manages resource allocation and shared infrastructure.

urea ycombinator

add to watch list Paper trade email alert is off

Femasys Inc

FEMY | $1.33 1.53% 1.5% 160K

|

(0.0% 1d) (-28.9% 1m) (48.8% 1y) (0.0% 2d) (-1.5% 3d) (-4.5% 7d) (-100.0% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 29,392,132

Sec Filling | Patents | 35 employees

our experienced management team has over 200 years of collective industry experience with extensive focus in medical devices. the pioneering and collaborative efforts of the management team have created an organization that strives for integrity in all actions, innovation in development activities, excellence in operations, and the highest quality products. the team is complemented by world-class medical advisors. our products have been organically conceived, researched and developed by the company and all manufacturing activities are conducted to ensure compliance with the u.s. food and drug administration (fda) per the requirements of 21 cfr 820, as well as iso 13485. femasys has achieved significant milestones to date, including numerous issued patents and filings, recruitment of a team of experts, clearance of multiple regulatory filings by the u.s. food and drug administration (fda), european union, canada, and japan with other select countries in process. making a difference in t

contraception

add to watch list Paper trade email alert is off

Icecure Medical Ltd

ICCM | $1.23 -4.03% 120K

|

(0.0% 1d) (7.9% 1m) (-8.2% 1y) (0.0% 2d) (0.0% 3d) (-5.1% 7d) (69.03% volume)
Earnings Calendar: 2023-08-14
Market Cap: $ 56,116,824
https://icecure-medical.com
Sec Filling | Patents | n/a employees

Founded in 2006, Israel-based IceCure Medical develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally-invasive technology is a safe and effective alternative to hospital surgical tumor removal that is easily performed in a relatively short procedure. The system is marketed and sold worldwide, after receiving FDA and CE approvals.

treatment cancer urea israel kidney lung cancer lungs

add to watch list Paper trade email alert is off

Better Choice Company Inc

BTTR | $6.17 0.44% -0.32% 29K

|

(0.0% 1d) (-13.2% 1m) (1161.8% 1y) (0.0% 2d) (0.0% 3d) (23.5% 7d) (4530.11% volume)
Earnings Calendar:
Market Cap: $ 5,513,518
https://www.betterchoicecompany.com
Sec Filling | Patents | 44 employees

Better Choice Company Inc. is a growing animal health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives. The company takes an alternative, nutrition-based approach to animal health relative to conventional dog and cat food offerings and position its portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. The company has a demonstrated, multi-decade track record of success selling trusted animal health and wellness products and leverage its established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. Better Choice sells the majority of its dog food, cat food and treats under the Halo and TruDog brands, which are focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats.

animals brands pets

add to watch list Paper trade email alert is off

Evotec SE - ADR

EVO | $7.15 -0.7% 19K

|

(0.0% 1d) (-5.2% 1m) (-26.3% 1y) (0.0% 2d) (0.4% 3d) (-1.8% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 2,533,756,025
https://www.evotec.com/
Sec Filling | Patents | 4200 employees

(DE) Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists.

add to watch list Paper trade email alert is off

Garrett Motion Inc - New

GTX | $9.36 1.08% 1.07% 800K

|

(0.0% 1d) (-6.4% 1m) (11.6% 1y) (0.0% 2d) (0.0% 3d) (-2.0% 7d) (-6.96% volume)
Earnings Calendar: 2024-02-15
Market Cap: $ 2,126,702,598
https://www.garrettmotion.com/
Sec Filling | Patents | 3 employees

(CH) Garrett Motion is a differentiated technology leader, serving customers worldwide for more than 65 years with passenger vehicle, commercial vehicle, aftermarket replacement and performance enhancement solutions. Garrett’s cutting-edge technology enables vehicles to become safer, more connected, efficient and environmentally friendly. The Company's portfolio of turbocharging, electric boosting and automotive software solutions empowers the transportation industry to redefine and further advance motion.

automotive eletrical vehicles

add to watch list Paper trade email alert is off

Minim Inc

MINM | $4.1 -11.83% -13.41% 50K

|

(0.0% 1d) (-28.8% 1m) (93.0% 1y) (0.0% 2d) (0.0% 3d) (-8.6% 7d) (-60.19% volume)
Earnings Calendar: 2024-04-16
Market Cap: $ 12,160,190
https://www.minim.com
Sec Filling | Patents | 73 employees

Minim, Inc. is the creator of innovative internet access products that dependably connect people to the information they need and the people they love. Headquartered in Manchester, NH, the company delivers smart software-driven communications products under the globally recognized Motorola brand and ZOOM® trademark. Minim end users benefit from a personalized and secure WiFi experience, leading to happy and safe homes where things just work.

communication security brands

add to watch list Paper trade email alert is off

NeuroPace Inc

NPCE S | $13.78 -1.57% -1.6% 96K

|

(0.0% 1d) (0.8% 1m) (197.6% 1y) (0.0% 2d) (0.0% 3d) (2.6% 7d) (-70.22% volume)
Earnings Calendar: 2024-03-05
Market Cap: $ 362,189,028
https://www.neuropace.com
Sec Filling | Patents | 167 employees

Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients suffering from drug-resistant epilepsy, and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

education treatment

add to watch list Paper trade email alert is off

Star Equity Holdings Inc

STRR | $0.889 4.53% 4.33% 9K

|

(0.0% 1d) (-4.1% 1m) (13.9% 1y) (0.0% 2d) (0.0% 3d) (-0.6% 7d) (-77.91% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 14,089,052
https://www.digirad.com/
Sec Filling | Patents | 636 employees

(US) Star Equity Holdings, Inc. is a diversified holding company committed to growing shareholder value through operational excellence and disciplined capital allocation.

add to watch list Paper trade email alert is off

Ventyx Biosciences Inc

VTYX | News | $4.47 2.76% 2.68% 910K

|

(0.0% 1d) (-41.6% 1m) (-88.1% 1y) (0.0% 2d) (0.0% 3d) (-6.2% 7d) (NaN% volume)
Earnings Calendar: 2023-11-02
Market Cap: $ 315,131,428
https://ventyxbio.com
Sec Filling | Patents | 2021 employees

(US) Ventyx Biosciences Inc. is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1 peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions.

treatment

add to watch list Paper trade email alert is off

Tempest Therapeutics Inc

TPST | $3.105 -2.05% -2.09% 380K

|

(0.0% 1d) (-13.0% 1m) (46.6% 1y) (0.0% 2d) (0.0% 3d) (-2.1% 7d) (44.61% volume)
Earnings Calendar: 2024-03-20
Market Cap: $ 68,906,241
https://www.millendo.com
Sec Filling | Patents | n/a employees

(United States) Millendo Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.

endocrine treatment

add to watch list Paper trade email alert is off

Blue Star Foods Corp.

BSFC | $0.0758 17.7% 15.04% 92M

|

(0.0% 1d) (-38.1% 1m) (-97.7% 1y) (0.0% 2d) (-14.3% 3d) (-14.3% 7d) (-81.99% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 3,083,739

Sec Filling | Patents | 16 employees

blue star foods inc. is an international seafood processor and importer. owning and operating several multinational production facilities and exporting seafood products to a global audience. one of the first seafood organizations to revolutionize its packaging with a patented system that has reduced its recycled materials and carbon footprint, saving millions of pounds of packaging from entering the environment. blue star foods has been one of the leaders in verifiable traceability and on the path to sustainability within the global seafood economy. coming soon will be the release of our technological advancements. these new applications will enhance our resource management best practices and benefit the end-user and consumer alike. the work we have done within the blue swimming crab specie allows our enterprise to enhance our supply chain efficiencies. our supply chain advancements transcend seamlessly into other species and categories.

education

add to watch list Paper trade email alert is off

Nuvve Holding Corp

NVVE | $0.6801 2.95% 2.87% 23K

|

(0.0% 1d) (-19.0% 1m) (6.2% 1y) (0.0% 2d) (0.0% 3d) (-1.7% 7d) (-48.1% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 4,128,149
https://nuvve.com
Sec Filling | Patents | 21 employees

Nuvve is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. Its mission is to lower the cost of electric vehicle ownership while supporting the integration of renewable energy sources, including solar and wind. Nuvve’s Grid Integrated Vehicle, GIVe™, platform is refueling the next generation of electric vehicle fleets through intelligent, bidirectional charging solutions. Since its founding in 2010, Nuvve has launched successful V2G projects on five continents and is deploying commercial services worldwide by developing partnerships with utilities, automakers, and electric vehicle fleets

energy electric vehicles solar vehicles renewable eletrical

add to watch list Paper trade email alert is off

Astria Therapeutics, Inc.

ATXS | $9.745 -7.54% -8.16% 1.2M

|

(0.0% 1d) (-29.4% 1m) (1.6% 1y) (0.0% 2d) (0.0% 3d) (1.9% 7d) (-1.66% volume)
Earnings Calendar: 2024-03-20
Market Cap: $ 535,030,329
https://astriatx.com
Sec Filling | Patents | 20 employees

Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by HAE and rare and niche allergic and immunological diseases.

add to watch list Paper trade email alert is off

← Previous
1
2
Next →

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

|

EGOX | $0.0515 43.06% 30.1% 330M

|

OLB 4 | $0.33 -14.95% 25.53% 840K

|

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

|

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

|

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M

|

Distribution Services

INSG | $3.03 25.21% 20.13% 330K

|

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K

|

WLGS | $0.59 18.0% 17.9% 2.3M

|

ASNS | $0.828 21.75% 17.86% 18K

|

Last 48 Hours Insiders Buying

RXO P 200000 | $19.37 2.32% 0.0% 1M

|

| 23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M

|

| 22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K

|

Health Technology

| 22:30
BCDA P 2750 | $0.377 -1.4% 97K

|

Health Technology

| 22:00
RMCF | $3.67 3.38% 3.27% 11K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar